Recently, IDH1 was reported to be up‐regulated in lung cancer tissues and could serve as novel plasma biomarker for the diagnosis of non‐small‐cell lung cancer (Sun et al., 2013; Tan et al., 2012). The gene discussed is IDH1; the disease is lung carcinoma.